Literature DB >> 26392226

Array CGH identifies copy number changes in 11% of 520 MDS patients with normal karyotype and uncovers prognostically relevant deletions.

S Volkert1, T Haferlach1, J Holzwarth1, M Zenger1, W Kern1, M Staller1, Y Nagata2, K Yoshida2, S Ogawa2, S Schnittger1, C Haferlach1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26392226     DOI： 10.1038/leu.2015.257

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

Authors:  Ulrike Bacher; Sandra Weissmann; Alexander Kohlmann; Sonja Schindela; Tamara Alpermann; Susanne Schnittger; Wolfgang Kern; Torsten Haferlach; Claudia Haferlach
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.

Authors:  Kathryn A Kolquist; Roger A Schultz; Aubry Furrow; Theresa C Brown; Jin-Yeong Han; Lynda J Campbell; Meaghan Wall; Marilyn L Slovak; Lisa G Shaffer; Blake C Ballif
Journal:  Cancer Genet       Date:  2011-11

4.  Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.

Authors:  Ayana Kon; Lee-Yung Shih; Masashi Minamino; Masashi Sanada; Yuichi Shiraishi; Yasunobu Nagata; Kenichi Yoshida; Yusuke Okuno; Masashige Bando; Ryuichiro Nakato; Shumpei Ishikawa; Aiko Sato-Otsubo; Genta Nagae; Aiko Nishimoto; Claudia Haferlach; Daniel Nowak; Yusuke Sato; Tamara Alpermann; Masao Nagasaki; Teppei Shimamura; Hiroko Tanaka; Kenichi Chiba; Ryo Yamamoto; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Tsuyoshi Nakamaki; Ken Ishiyama; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Shigeru Chiba; Hiraku Mori; Hiromitsu Nakauchi; H Phillip Koeffler; Hiroyuki Aburatani; Torsten Haferlach; Katsuhiko Shirahige; Satoru Miyano; Seishi Ogawa
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

5.  International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors:  P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

6.  Clinical significance of Y chromosome loss in hematologic disease.

Authors:  A Wiktor; B A Rybicki; Z S Piao; M Shurafa; B Barthel; K Maeda; D L Van Dyke
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

7.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

8.  Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.

Authors:  Azim Mohamedali; Joop Gäken; Natalie A Twine; Wendy Ingram; Nigel Westwood; Nicholas C Lea; Janet Hayden; Nora Donaldson; Carlo Aul; Norbert Gattermann; Aristotle Giagounidis; Ulrich Germing; Alan F List; Ghulam J Mufti
Journal:  Blood       Date:  2007-07-18       Impact factor: 22.113

9.  TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.

Authors:  Y Sato; Y Suto; J Pietenpol; T R Golub; D G Gilliland; E M Davis; M M Le Beau; J M Roberts; B Vogelstein; J D Rowley
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
View more
  8 in total

Review 1.  The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).

Authors:  F Nguyen-Khac; A Bidet; A Daudignon; M Lafage-Pochitaloff; G Ameye; C Bilhou-Nabéra; E Chapiro; M A Collonge-Rame; W Cuccuini; N Douet-Guilbert; V Eclache; I Luquet; L Michaux; N Nadal; D Penther; B Quilichini; C Terre; C Lefebvre; M-B Troadec; L Véronèse
Journal:  Leukemia       Date:  2022-04-16       Impact factor: 12.883

2.  Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.

Authors:  Andrew G Evans; Ausaf Ahmad; W Richard Burack; M Anwar Iqbal
Journal:  Mod Pathol       Date:  2016-07-08       Impact factor: 7.842

3.  Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization for detecting chromosome abnormalities in myelodysplastic syndromes: A retrospective study.

Authors:  Xiaofei Ai; Bing Li; Zefeng Xu; Jinqin Liu; Tiejun Qin; Qinghua Li; Zhijian Xiao
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

4.  Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.

Authors:  Jingya Wang; Xiaofei Ai; Tiejun Qin; Zefeng Xu; Yue Zhang; Jinqin Liu; Bing Li; Liwei Fang; Hongli Zhang; Lijuan Pan; Naibo Hu; Shiqiang Qu; Wenyu Cai; Kun Ru; Yujiao Jia; Gang Huang; Zhijian Xiao
Journal:  Oncotarget       Date:  2017-01-03

5.  Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients.

Authors:  Jing Ma; Xiaofei Ai; Jinhuan Wang; Limin Xing; Chen Tian; Hongliang Yang; Yong Yu; Haifeng Zhao; Xiaofang Wang; Zhigang Zhao; Yafei Wang; Zeng Cao
Journal:  Ann Hematol       Date:  2021-05-15       Impact factor: 3.673

6.  Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.

Authors:  Elena Ciabatti; Angelo Valetto; Veronica Bertini; Maria Immacolata Ferreri; Alice Guazzelli; Susanna Grassi; Francesca Guerrini; Iacopo Petrini; Maria Rita Metelli; Maria Adelaide Caligo; Simona Rossi; Sara Galimberti
Journal:  Oncotarget       Date:  2017-03-25

Review 7.  Techniques for detecting chromosomal aberrations in myelodysplastic syndromes.

Authors:  Qibin Song; Min Peng; Yuxin Chu; Shiang Huang
Journal:  Oncotarget       Date:  2017-05-09

8.  Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome.

Authors:  Cecilia C S Yeung; Scott McElhone; Xue Yan Chen; David Ng; Barry E Storer; H Joachim Deeg; Min Fang
Journal:  Mod Pathol       Date:  2017-12-15       Impact factor: 7.842
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.